Orthopedic, Prosthetic & Surgical Appliances & Supplies
Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufacture and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.
In the chart Earnings are multiplied by this value.
High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.
Years | 12-2015 | 12-2016 | 12-2017 | 12-2018 | 12-2019 | 12-2020 | 12-2021 | 12-2022 | 12-2023 | TTM |
---|---|---|---|---|---|---|---|---|---|---|
Net Margin | 4.2% | 3.5% | -2.2% | 3.8% | -16% | 1.4% | 1.9% | -0.85% | -1.9% | -4.5% |
ROA | 4.2% | 3.7% | 0.43% | 3.6% | 2.8% | 2.2% | 3% | -0.048% | -1.5% | -1.4% |
ROE | 5.2% | 4.1% | -2% | 4% | -15% | 1.2% | 1.5% | -0.39% | -0.97% | -2.5% |
The average Net Margin over the past 5 years is -1.93%.
The trend of Net Margin over the past 5 years is +0.48%.
The average ROA over the past 5 years is +1.68%.
The trend of ROA over the past 5 years is -0.94%.
The average ROE over the past 5 years is -1.62%.
The trend of ROE over the past 5 years is +0.56%.
Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.
Years | 12-2015 | 12-2016 | 12-2017 | 12-2018 | 12-2019 | 12-2020 | 12-2021 | 12-2022 | 12-2023 | TTM |
---|---|---|---|---|---|---|---|---|---|---|
Debt FCF | 6.12 | 7.10 | 7.17 | 7.73 | 425.02 | 12.15 | 8.35 | -2.97 | 37.60 | -36.39 |
Debt Equity | 0.44 | 0.42 | 0.29 | 0.35 | 0.68 | 0.63 | 0.45 | 0.14 | 0.14 | 0.41 |
MIN | ||||||||||
Graham Stability | - | - | -33% | 100% | -810% | - | - | - | -99% | -810% |
The Debt/FCF trailing twelve month is -36.39.
The trend of Debt/FCF over the past 5 years is -32.53.
Graham’s Stability measure stands at -8.10.
Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.
Years | 12-2016 | 12-2018 | 12-2020 | 12-2022 | Trend |
---|---|---|---|---|---|
Revenue | -10% | -14% | -18% | 9.2% | -0.15% |
Net Income | - | - | - | - | 20% |
Stockholders Equity | 1.4% | -0.33% | -1.6% | -0.84% | -0.44% |
FCF | -32% | -39% | -59% | - | 240% |
The Revenue CAGR over the past 5 years is -14.18%.
The trend of Revenue growth rate over the past 5 years is -0.15%.
The Earnings CAGR over the past 5 years is -.
The trend of Earnings growth rate over the past 5 years is +19.78%.
The Equity CAGR over the past 5 years is -0.33%.
The trend of Equity growth rate over the past 5 years is -0.44%.
The FCF CAGR over the past 5 years is -39.44%.
The trend of FCF growth rate over the past 5 years is +238.74%.